• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效抗逆转录病毒疗法引入前后美国HIV感染女性的临床和免疫进展

Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy.

作者信息

Mayer Kenneth H, Hogan Joseph W, Smith Dawn, Klein Robert S, Schuman Paula, Margolick Joseph B, Korkontzelou Christina, Farzedegan Homayoon, Vlahov David, Carpenter Charles C J

机构信息

Miriam Hospital and dagger Brown University, Providence, Rhode Island 02906, USA.

出版信息

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):614-24. doi: 10.1097/00126334-200308150-00011.

DOI:10.1097/00126334-200308150-00011
PMID:12902807
Abstract

OBJECTIVE

To examine factors associated with clinical and immunologic HIV disease progression in a cohort of US women.

DESIGN

Analysis of data from a prospective, longitudinal, case-control study of HIV-infected women followed every 6 months for 7 years.

SETTING

Four urban clinical centers in the United States.

PARTICIPANTS

648 HIV-infected women who did not have AIDS at time of entry into the study.

MEASUREMENTS

Structured clinical and behavioral interviews; protocol-directed physical examinations; CD4 lymphocyte counts; plasma HIV RNA; infectious pathogen serologies. RESULTS With 2304 women-years of follow-up, 46.1% of the women developed AIDS; however, 93.3% of the diagnoses were based on CD4 counts dropping to <200 cells/mm(3). Only 10.6% of the women with CD4 counts <200 cells/mm(3) developed an opportunistic infection. Baseline CD4 count was the strongest predictor of subsequent clinical progression. Illicit substance use, multiple pregnancies, demographic variables, and other infections were not associated with progression. Among women with CD4 counts >500 cells/mm(3) at baseline, those who were anemic or had hepatitis C were more likely to progress to AIDS. By the end of the study, only 52% of the participants were on highly active antiretroviral therapy (HAART).

CONCLUSIONS

Despite underutilization of HAART in this multicenter cohort of urban women, opportunistic infections were uncommon, despite CD4 declines.

摘要

目的

研究美国女性队列中与临床及免疫性HIV疾病进展相关的因素。

设计

对一项前瞻性、纵向、病例对照研究的数据进行分析,该研究对HIV感染女性每6个月随访一次,持续7年。

地点

美国四个城市临床中心。

参与者

648名在进入研究时未患艾滋病的HIV感染女性。

测量指标

结构化临床及行为访谈;按方案进行的体格检查;CD4淋巴细胞计数;血浆HIV RNA;感染性病原体血清学检查。结果 在2304人年的随访中,46.1%的女性发展为艾滋病;然而,93.3%的诊断是基于CD4计数降至<200个细胞/mm³。CD4计数<200个细胞/mm³的女性中只有10.6%发生了机会性感染。基线CD4计数是后续临床进展的最强预测因素。使用违禁药物、多次怀孕、人口统计学变量及其他感染与疾病进展无关。在基线时CD4计数>500个细胞/mm³的女性中,贫血或感染丙型肝炎的女性更易发展为艾滋病。到研究结束时,只有52%的参与者接受了高效抗逆转录病毒治疗(HAART)。

结论

尽管在这个城市女性多中心队列中HAART的使用不足,但尽管CD4计数下降,机会性感染并不常见。

相似文献

1
Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy.高效抗逆转录病毒疗法引入前后美国HIV感染女性的临床和免疫进展
J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):614-24. doi: 10.1097/00126334-200308150-00011.
2
Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.使用基于生物标志物的疾病进展等效性评估高效抗逆转录病毒疗法对人类免疫缺陷病毒感染者的有效性。
Am J Epidemiol. 2002 Apr 15;155(8):760-70. doi: 10.1093/aje/155.8.760.
3
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.强效抗逆转录病毒治疗开始后出现的艾滋病相关机会性感染:瑞士HIV队列研究
JAMA. 1999 Dec 15;282(23):2220-6. doi: 10.1001/jama.282.23.2220.
4
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.处于疾病不同阶段开始高效抗逆转录病毒治疗的HIV-1感染女性进展为艾滋病和死亡的风险。
Arch Intern Med. 2002 Sep 23;162(17):1973-80. doi: 10.1001/archinte.162.17.1973.
5
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.丙型肝炎感染对HIV疾病进展及初始抗逆转录病毒治疗早期反应的影响。
AIDS. 2006 May 12;20(8):1171-9. doi: 10.1097/01.aids.0000226958.87471.48.
6
Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.设定人类免疫缺陷病毒(HIV)感染患者开始高效抗逆转录病毒治疗的最低CD4细胞计数阈值。
HIV Med. 2007 Apr;8(3):181-5. doi: 10.1111/j.1468-1293.2007.00450.x.
7
Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.中国广西地区 HIV/AIDS 患者在接受高效抗逆转录病毒治疗(HAART)的第一年中,T 细胞亚群的动态变化及其与口腔和全身机会性感染的关系。
J Med Virol. 2015 Jul;87(7):1158-67. doi: 10.1002/jmv.24177. Epub 2015 Mar 16.
8
Associated factors for progression to AIDS among HIV-infected people who use drugs: a retrospective cohort study in Dongguan, China.中国东莞一项针对吸毒 HIV 感染者向艾滋病进展的相关因素的回顾性队列研究。
BMJ Open. 2019 Jul 3;9(7):e023841. doi: 10.1136/bmjopen-2018-023841.
9
[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].[高效抗逆转录病毒治疗时代晚期HIV感染患者病情进展和死亡的预测因素]
Enferm Infecc Microbiol Clin. 2004 Mar;22(3):142-9. doi: 10.1016/s0213-005x(04)73054-2.
10
Hepatitis C and progression of HIV disease.丙型肝炎与艾滋病病情进展
JAMA. 2002 Jul 10;288(2):199-206. doi: 10.1001/jama.288.2.199.

引用本文的文献

1
Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital Tract.原虫-病毒-细菌合并感染改变女性生殖道中的半乳糖凝集素水平和相关免疫介质。
Front Cell Infect Microbiol. 2021 Aug 5;11:649940. doi: 10.3389/fcimb.2021.649940. eCollection 2021.
2
Diversity of the hepatitis C virus NS5B gene during HIV co-infection.丙型肝炎病毒 NS5B 基因在 HIV 合并感染期间的多样性。
PLoS One. 2020 Aug 4;15(8):e0237162. doi: 10.1371/journal.pone.0237162. eCollection 2020.
3
Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.
与 HIV 感染妇女中人 Pegivirus(HPgV)感染相关的细胞因子/趋化因子表达。
J Med Virol. 2017 Nov;89(11):1904-1911. doi: 10.1002/jmv.24836. Epub 2017 Aug 28.
4
GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection.丙型肝炎病毒(HCV)血清学阳性且感染人类免疫缺陷病毒(HIV)或有感染风险的女性中的GB病毒C(GBV-C)感染
PLoS One. 2014 Dec 10;9(12):e114467. doi: 10.1371/journal.pone.0114467. eCollection 2014.
5
Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco.在摩洛哥使用FIB4指数的人类免疫缺陷病毒单一感染患者中肝纤维化的危险因素
World J Hepatol. 2013 Oct 27;5(10):584-8. doi: 10.4254/wjh.v5.i10.584.
6
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.HIV 单一感染与 FIB-4(一种非侵入性的肝纤维化指数)相关,这在女性中更为明显。
Clin Infect Dis. 2011 Mar 1;52(5):674-80. doi: 10.1093/cid/ciq199. Epub 2011 Jan 19.
7
Women facing HIV. Key question on women with HIV infection: Italian consensus workshop.面临艾滋病毒感染的女性。关于感染艾滋病毒女性的关键问题:意大利共识研讨会。
Infection. 2009 Apr;37(2):168-78. doi: 10.1007/s15010-008-7361-7. Epub 2009 Mar 23.
8
Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.HIV感染孕妇的弓形虫抗体谱与先天性弓形虫病的风险
Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):345-51. doi: 10.1007/s10096-008-0631-2. Epub 2008 Oct 15.
9
Bayesian semiparametric regression for longitudinal binary processes with missing data.用于具有缺失数据的纵向二元过程的贝叶斯半参数回归
Stat Med. 2008 Jul 30;27(17):3247-68. doi: 10.1002/sim.3265.
10
Reproductive decision-making among HIV-Infected women.感染艾滋病毒女性的生殖决策
J Natl Med Assoc. 2005 Oct;97(10):1403-10.